Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Observed Findings

• CoQ10 functions as an essential cofactor in mitochondrial ATP production and possesses antioxidant, anti-inflammatory, and neuroprotective properties.
• CoQ10 depletion is observed in multiple conditions including ME/CFS, fibromyalgia, depression, and Parkinson's disease.
• Clinical studies show CoQ10 supplementation reduces fatigue and improves exercise performance in ME/CFS patients.
• CoQ10 treatment demonstrates antidepressive effects and reduces pain/hyperalgesia in fibromyalgia patients.
• CoQ10 may slow disease progression in Parkinson's disease and improve quality of life across studied conditions.

Inferred Conclusions

• CoQ10 depletion may be a shared pathophysiological feature in ME/CFS and related neuropsychiatric and neurological disorders.
• CoQ10 supplementation has potential as a therapeutic intervention for exercise intolerance and fatigue in ME/CFS by restoring mitochondrial bioenergetic capacity and reducing oxidative stress.
• The therapeutic effects of CoQ10 across multiple conditions suggest a common mechanism involving mitochondrial dysfunction and cellular energy failure.
• CoQ10 supplementation represents a relatively safe, evidence-informed approach warranting further rigorous clinical investigation in ME/CFS populations.

Remaining Questions